Emerging Specialty Pharmaceutical Company to Deploy Full Suite of iContracts Solutions
Raritan, NJ – January 6, 2015 – iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced ANI Pharmaceuticals has selected iContracts full suite of solutions to manage commercial contracts and help ensure compliance with Government pricing programs including Medicaid, state programs and associated calculations and reporting. iContracts solutions help life science companies optimize performance by streamlining and improving their contracting, revenue management, and government compliance processes.
“As we evaluated options for effectively managing our compliance and revenue management processes, it became clear that iContracts offered not only the best solution, but a robust platform to support future growth,” commented Charlotte Arnold, CFO for ANI Pharmaceuticals. “We are very confident in our decision to utilize the iContracts suite of solutions and look forward to implementing the software to enhance our customer experience and provide additional efficiency to ANI Pharmaceuticals.”
ANI Pharmaceuticals will utilize iContracts Chargeback Payer, Rebate Payer, Class of Trade, Medicaid Payer, Medicare GAP, Government Pricing, Analytics/Reporting and Universal Contract Manager. These solutions are proven to strengthen compliance and revenue management processes.
“We are pleased to welcome another fast growing pharmaceutical company to the iContracts family and are honored to serve ANI Pharmaceuticals with our highly scalable cloud based Better Contracting Solutions platform,” noted Leigh Powell, Chief Executive Officer of iContracts. “ANI’s commitment to providing high quality speciaity pharmaceutical products has improved countless lives and formed the very foundation of their dramatic growth. We look forward to a strong relationship for years to come with ANI Pharmaceuticals.”
iContracts suite of fully integrated solutions manages all aspects of a company’s contracting processes, including, processing chargebacks, rebates, Medicaid rebates, Medicare GAP payments, other incentive agreements, Government Pricing compliance at all levels, and advanced Gross-To-Net analysis. They also provide a flexible central repository for contracts of any type.
iContracts’ solutions are available as an “on demand” service or as a behind-the-firewall offering and are built on iContracts’ revolutionary BCS platform featuring an advanced data architecture, rich functionality and Simplified Common User Interface (SCUI) enabling users to execute any process after learning just two basic page formats. This groundbreaking design drastically reduces implementation; training and future upgrade timeframes and costs.
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by understanding a few core concepts, iContracts solutions are backed by the most highly evolved cloud-based architecture in the industry, built by technologists with extensive contract management experience. iContracts comprehensive suite of solutions revolutionize how organizations think about and manage all aspects of a company’s contract management process, transforming it from an unwieldy collection of spreadsheets, customer applications, filing cabinets, and scattered electronic directories to a powerful tool that aligns strategy with execution, while simultaneously insuring greater visibility into commitments and the ability of companies to support growing needs for regulatory reporting and audits. Our solutions are enterprise-class and can be quickly and easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company’s targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit www.anipharmaceuticals.com.